Zymeworks Inc.
ZYME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.56 | 0.03 | -0.03 | -0.30 |
| FCF Yield | -10.19% | -17.10% | 25.56% | -24.08% |
| EV / EBITDA | -10.08 | -4.84 | 0.95 | -3.32 |
| Quality | ||||
| ROIC | -33.39% | -24.82% | 21.44% | -67.52% |
| Gross Margin | 85.33% | -88.11% | 49.40% | -647.90% |
| Cash Conversion Ratio | 0.90 | 1.00 | 1.16 | 0.91 |
| Growth | ||||
| Revenue 3-Year CAGR | -43.02% | 41.76% | 119.60% | -3.34% |
| Free Cash Flow Growth | 7.57% | -193.43% | 163.67% | -30.49% |
| Safety | ||||
| Net Debt / EBITDA | 0.45 | 1.08 | -2.53 | 0.82 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 139.72 | 77.67 | 15.80 | 204.15 |